Drug Shortage Report for CHOLESTYRAMINE-ODAN

Last updated on 2025-04-15 History
Report ID 204546
Drug Identification Number 02455609
Brand name CHOLESTYRAMINE-ODAN
Common or Proper name Cholestyramine for Oral Suspension, USP
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) CHOLESTYRAMINE RESIN
Strength(s) 4G
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30 sachets
ATC code C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-09-18
Estimated end date Unknown
Actual end date 2025-04-14
Shortage status Resolved
Updated date 2025-04-15
Company comments
Health Canada comments
Tier 3 Status Yes
Company contact information [email protected] Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-04-15 English Compare
v15 2025-04-14 French Compare
v14 2025-04-14 English Compare
v13 2024-01-30 English Compare
v12 2024-01-23 French Compare
v11 2024-01-23 English Compare
v10 2024-01-22 French Compare
v9 2024-01-22 English Compare
v8 2024-01-15 French Compare
v7 2024-01-15 English Compare
v6 2023-11-24 French Compare
v5 2023-11-24 English Compare
v4 2023-11-24 English Compare
v3 2023-09-19 English Compare
v2 2023-09-15 French Compare
v1 2023-09-15 English Compare

Showing 1 to 16 of 16